S

AN FRANCISCO — Vice President Joe Biden on Monday told a packed ballroom of biopharma investors and executives that after leaving the White House he plans to push their industry to make drugs affordable for patients.

“We’re going to convene a national conversation with pharmaceutical companies— many of you who are here … biotech companies and others — to ensure patients can afford treatments,” Biden said. “Too many Americans are forced to sell their homes, to go into bankruptcy, so their loved ones can get care and hope for a cure. This needs to change while still not undermining the profit motive making sure there’s a genuine reward for effort.”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Need this corporate war brought under control right now because it is a war, there are far more casualties from this ‘maximise return to shareholders’ mentality- it is actually warlords holding governments and individuals to ransom. There is little or no relationship between drug development and price. Hep C affects 2% of the world, is curable, yet 2 million have died in 2 years because of the deliberately murderous price. I am one of those nominated to die as ‘leverage’ to force health systems and insurance companies to buy for nearly 100k what costs about 500 to make. I escaped by finding the buyers club option- generic hep C medication- which is rescuing 1000’s of people safely, and legally. Identical meds, clinical trials- I don’t work for anyone, but trying to spread the word, as this is how I survived. Please share, look up those things, or me, or fixhepc.

  • So, where was he over the past eight years as the exorbitant pricing of drugs had no limits, and was only encouraged to further increase under ACA?

    Was he paid to speak before Big Pharma?

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X